搜索临床试验以:正常剂量NK细胞×4次
总计165个结果
-
Biohaven Pharmaceuticals, Inc.Dana-Farber Cancer Institute招聘中
-
Baylor College of MedicineUniversity of Texas, Southwestern Medical Center at Dallas完全的
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Sponsor GmbH完全的
-
Institute of Hematology & Blood Diseases HospitalHangzhou Qihan Biotech Co.,Ltd.尚未招聘
-
Joaquín Martínez López, MD, PhDHospital Infantil Universitario Niño Jesús, Madrid, Spain完全的
-
Marijn Lijffijt, PhDMichael E. DeBakey VA Medical Center; VistaGen Therapeutics, Inc.完全的
-
MAXVAX Biotechnology Limited Liability CompanyHenan Center for Disease Control and Prevention主动,不招人
-
Medical University of ViennaPolymun Scientific, Vienna, Austria完全的
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Altor BioScience; Miltenyi Biomedicine GmbH招聘中
-
Assistance Publique - Hôpitaux de Paris招聘中
-
James J. Peters Veterans Affairs Medical CenterKessler Institute for Rehabilitation未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline完全的
-
Federal University of Rio Grande do SulCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.完全的
-
Fred Hutchinson Cancer CenterMedexus Pharma, Inc.招聘中
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZeneca完全的
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey Clinic完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的套细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性惰性成人非霍奇金淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 复发性惰性成人非霍奇金淋巴瘤美国
-
Stanford UniversityWashington University School of Medicine; Duke University; University of Washington; University... 和其他合作者邀请报名
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销套细胞淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | CD19阳性美国
-
Pirogov Russian National Research Medical UniversityRussian Academy of Medical Sciences未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中急性髓性白血病 | 高危骨髓增生异常综合征 | 母细胞期慢性粒细胞白血病,BCR-ABL1 阳性 | 费城染色体阳性 | 骨髓增殖性肿瘤 | 骨髓肉瘤 | 破坏 10% 或更多的骨髓有核细胞美国
-
GlaxoSmithKline完全的